An Open-label, Single-dose, Randomized, Two-way Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 22 Oct 2012
At a glance
- Drugs Oxycodone/naltrexone (Primary) ; Oxycodone
- Indications Pain
- Focus Pharmacokinetics
- 15 Oct 2012 Planned End Date added to 1 Oct 2012 as reported by ClinicalTrials.gov.
- 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Sep 2012 New trial record